Earnings calendar

BridgeBio Pharma, Inc. (BBIO) earnings: date, estimates, results and stock reactions

Over the last 12 reports the stock moved 3.0% on average (either way), rising 5 times and falling 7. EPS beat estimates 5 of 12 times; revenue 8 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).

QuarterReportedEPSEPS estimateEPS surpriseRevenueRevenue estimateStock move
Q3 FY20262026-10-29-0.42-0.54+22.5%353.2M293.5M+5.8%
Q2 FY20262026-08-10-0.78-0.58-35.5%243.7M220.9M-0.9%
Q1 FY20262026-05-07-0.84-0.68-23.8%194.5M178.1M-1.0%
Q4 FY20252026-02-24-1.00-0.71-40.2%154.2M146.8M-2.0%
Q3 FY20252025-10-29-0.95-0.88-8.0%120.7M148.2M-1.8%
Q2 FY20252025-08-05-0.95-0.83-14.5%110.6M108.1M-6.2%
Q1 FY20252025-04-29-0.88-1.00+12.0%116.6M68.4M+6.9%
Q4 FY20242025-02-20-1.31-1.09-20.2%5.9M4.0M+1.5%

BBIO stock report · Earnings calendar